Iovance Biotherapeutics Inc
F:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
Tesmec SpA
F:2GV
|
IT |
Multiples-Based Value
The Multiples-Based Value for
Iovance Biotherapeutics Inc (2LB) under the Base Case is 8.56 EUR.
Compared with the current market price of 3.62 EUR, the stock appears
Undervalued by 58% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.